AU2002333447A1 - Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity - Google Patents
Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesityInfo
- Publication number
- AU2002333447A1 AU2002333447A1 AU2002333447A AU2002333447A AU2002333447A1 AU 2002333447 A1 AU2002333447 A1 AU 2002333447A1 AU 2002333447 A AU2002333447 A AU 2002333447A AU 2002333447 A AU2002333447 A AU 2002333447A AU 2002333447 A1 AU2002333447 A1 AU 2002333447A1
- Authority
- AU
- Australia
- Prior art keywords
- prophylaxis
- obesity
- systems
- treatment
- producing drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical class C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 230000000069 prophylaxis Effects 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10142659.3 | 2001-08-31 | ||
DE10142659A DE10142659A1 (en) | 2001-08-31 | 2001-08-31 | Use of multiply substituted indan-1-ol. Systems for the preparation of medicaments for the prophylaxis or treatment of obesity |
PCT/EP2002/009200 WO2003020255A1 (en) | 2001-08-31 | 2002-08-17 | Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002333447A1 true AU2002333447A1 (en) | 2003-06-05 |
AU2002333447B2 AU2002333447B2 (en) | 2006-10-26 |
Family
ID=7697230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002333447A Ceased AU2002333447B2 (en) | 2001-08-31 | 2002-08-17 | Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity |
Country Status (10)
Country | Link |
---|---|
US (3) | US6686397B2 (en) |
EP (1) | EP1425000B1 (en) |
JP (1) | JP2005507382A (en) |
AU (1) | AU2002333447B2 (en) |
CA (1) | CA2458553A1 (en) |
DE (1) | DE10142659A1 (en) |
IL (1) | IL160600A0 (en) |
MX (1) | MXPA04001847A (en) |
PE (1) | PE20030363A1 (en) |
WO (1) | WO2003020255A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10142663B4 (en) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituted indan-1-ol systems |
DE10142661B4 (en) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Poly-substituted indan-1-ol systems and their use as pharmaceuticals |
JP4774763B2 (en) * | 2004-03-25 | 2011-09-14 | 住友化学株式会社 | Method for producing purified 3-methyl-2-butenyl acetate |
US20050238979A1 (en) * | 2004-04-08 | 2005-10-27 | Christophe Dumousseaux | Compositions for application to the skin, to the lips, to the nails, and/or to hair |
US20050257715A1 (en) * | 2004-04-08 | 2005-11-24 | Christophe Dumousseaux | Compositions for application to the skin, to the lips, to the nails, and/or to hair |
ATE442064T1 (en) * | 2004-10-05 | 2009-09-15 | Oreal | MAKEUP KIT AND PROCEDURE |
FR2876011B1 (en) * | 2004-10-05 | 2006-12-29 | Oreal | METHOD FOR MAKE-UP A SUPPORT AND KIT FOR IMPLEMENTING SAID METHOD |
US9649261B2 (en) | 2004-10-05 | 2017-05-16 | L'oreal | Method of applying makeup to a surface and a kit for implementing such a method |
KR100693528B1 (en) * | 2004-10-29 | 2007-03-14 | 주식회사 팬택 | Wireless communication terminal for delaying power on |
FR2888115B1 (en) * | 2005-07-08 | 2013-02-15 | Oreal | LIQUID FOUNDATION, MAKE - UP PROCESS AND KIT FOR IMPLEMENTING SUCH A METHOD. |
FR2889921B1 (en) | 2005-08-30 | 2007-12-28 | Oreal | CONDITIONING AND APPLICATION ASSEMBLY COMPRISING A MAGNETIC DEVICE. |
DE102013009631A1 (en) * | 2013-06-10 | 2014-12-11 | Forschungszentrum Jülich GmbH | Process for the preparation of cathin |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2345146C3 (en) | 1973-09-07 | 1981-08-06 | Feinmechanische Werke Mainz Gmbh, 6500 Mainz | Hydraulic actuator |
FR2345146A1 (en) * | 1976-03-23 | 1977-10-21 | Logeais Labor Jacques | Anorexigenic and lipolytic agent - contg. hydroxy-indanyl propanol for treating obesity |
DE2965279D1 (en) * | 1978-07-27 | 1983-06-01 | Schering Ag | Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds |
DE3103372A1 (en) * | 1981-01-27 | 1982-09-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | NEW INDANYL DERIVATIVES, THEIR PRODUCTION AND USE |
DE69629387T2 (en) * | 1995-12-06 | 2004-06-24 | Venantius Ltd. | DIMERE INDAN COMPOUNDS AND THEIR PHARMACEUTICAL USE |
HUP9902056A3 (en) | 1996-01-17 | 2002-02-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
JP3149958B2 (en) | 1996-08-30 | 2001-03-26 | ノボ ノルディスク アクティーゼルスカブ | GLP-1 derivative |
PT958296E (en) | 1996-12-31 | 2003-11-28 | Reddys Lab Ltd Dr | HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND ITS UTILIZATION IN THE TREATMENT OF RELATED DIABETES AND DISEASES |
WO1999003861A1 (en) | 1997-07-16 | 1999-01-28 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
US5987946A (en) | 1997-08-15 | 1999-11-23 | Watts; James A. | Lock picking method and apparatus |
FR2796070B1 (en) * | 1999-07-06 | 2003-02-21 | Lipha | BENZODIAZEPINES DERIVATIVES FOR USE IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF PREPARATION |
EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
ATE283265T1 (en) * | 2000-02-23 | 2004-12-15 | Aventis Pharma Gmbh | 8,8A-DIHYDRO-INDENO (1,2-D)THIAZOLE DERIVATIVES THAT ARE SUBSTITUTED IN THE 8A POSITION, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS, E.G. AS ANORECTIC AGENTS |
DE10142662B4 (en) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivatives of C2-substituted indan-1-ol systems and their use as pharmaceuticals |
DE10142661B4 (en) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Poly-substituted indan-1-ol systems and their use as pharmaceuticals |
-
2001
- 2001-08-31 DE DE10142659A patent/DE10142659A1/en not_active Withdrawn
-
2002
- 2002-08-17 CA CA002458553A patent/CA2458553A1/en not_active Abandoned
- 2002-08-17 JP JP2003524564A patent/JP2005507382A/en not_active Withdrawn
- 2002-08-17 MX MXPA04001847A patent/MXPA04001847A/en active IP Right Grant
- 2002-08-17 WO PCT/EP2002/009200 patent/WO2003020255A1/en active Application Filing
- 2002-08-17 EP EP02797584A patent/EP1425000B1/en not_active Expired - Lifetime
- 2002-08-17 AU AU2002333447A patent/AU2002333447B2/en not_active Ceased
- 2002-08-17 IL IL16060002A patent/IL160600A0/en unknown
- 2002-08-23 PE PE2002000812A patent/PE20030363A1/en not_active Application Discontinuation
- 2002-08-29 US US10/230,353 patent/US6686397B2/en not_active Expired - Lifetime
-
2003
- 2003-10-27 US US10/692,721 patent/US6812257B2/en not_active Expired - Lifetime
- 2003-10-27 US US10/692,734 patent/US6812256B2/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003254038A1 (en) | Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer | |
AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
AU2001247331A1 (en) | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders | |
WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
AU2003216592A1 (en) | Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases | |
AU2002258428A1 (en) | Methods for the treatment of metabolic disorders, including obesity and diabetes | |
AU2002333447A1 (en) | Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity | |
IL160600A0 (en) | Use of polysubstituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity | |
AU2002364171A1 (en) | Materials and methods for the treatment or prevention of obesity | |
AU2003224002A1 (en) | Drugs for the arthritis treatment | |
AU2002237783A1 (en) | Pillows for the physically disabled person | |
AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
AU2002236781A1 (en) | Treatment for snoring | |
AU2003238242A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
AU3593599A (en) | Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof | |
AU2003282626A1 (en) | Use of flavonoid for the treatment of overweight and the reduction of the mammalian appetite | |
AU2002342615A1 (en) | Use of derivatives of C2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity | |
AU2002315485A1 (en) | Compositions and methods for the treatment of body weight disorders, including obesity | |
AU2002333448A1 (en) | Derivatives of C2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments | |
AU2002336984A1 (en) | Use of C2-substituted Indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity | |
AU2002336985A1 (en) | Use of C2-substituted Indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity | |
AU2002366195A1 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
IL160607A0 (en) | Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity | |
AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i |